The therapeutic potential of extra terminal domain inhibitor (iBET) has increasing studies both in oncology and immunoinflammatory. Moreover, iBETs are…
In our previous blogs, we have introduced two HBV inhibitors. Today, I’d like to describe another small molecule compound BA-53038B…